News
CRY
--
0.00%
--
CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Morgan Stanley Global Healthcare Conference.
PR Newswire · 09/08 20:47
CryoLife announces acquisition of aortic repair device developer
CryoLife (CRY) acquires Florida-based Ascyrus Medical for up to $200M, including $60M cash and $20M shares of CryoLife's common stock in upfront payment.Ascyrus is a privately-held developer of the Ascyrus Medical Dissection Stent ((AMDS)),
Seekingalpha · 09/02 21:44
CryoLife Acquires Ascyrus Medical
CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has acquired Ascyrus Medical LLC (Ascyrus). Ascyrus is a Florida-based, privately-held developer of the Ascyrus Medical Dissection Stent (AMDS™), the world
PR Newswire · 09/02 21:02
Needham's medtech look sees continued gains through year-end, names picks
All evidence indicates the medical technology sector hit its trough in April, as each month since has brought sequential improvement - from a springtime hole where elective medical procedures faced
Seekingalpha · 08/31 22:54
CryoLife to Participate in Upcoming Virtual Investor Conferences
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences.
PR Newswire · 08/06 12:35
CryoLife's (CRY) CEO Pat Mackin on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha · 07/31 04:00
CryoLife (CRY) Reports Q2 Loss, Tops Revenue Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 33.33% and 4.82%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 07/30 23:40
Cryolife Q2 EPS $(0.02) Beats $(0.14) Estimate, Sales $53.80M Beat $50.47M Estimate
Cryolife (NYSE:CRY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.14) by 85.71 percent. This is a 118.18 percent decrease over earnings of $0.11 per share from the same
Benzinga · 07/30 20:13
CryoLife Reports Second Quarter 2020 Financial Results
Second Quarter and Recent Business Highlights:
PR Newswire · 07/30 20:05
CryoLife EPS beats by $0.07, beats on revenue
Seeking Alpha · 07/30 04:00
Notable earnings after Thursday's close
Seeking Alpha · 07/29 04:00
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/23 16:32
CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results will be released on Thursday, July 30, 2020 after the market closes. On that day, the Company will
PR Newswire · 07/21 21:00
CryoLife prices $100M convertible debt offering
Seeking Alpha - Article · 06/19 12:38
Coronavirus update: 100 days since COVID-19 declared a pandemic, and U.S. has highest case and death tallies by a wide margin
A full 100 days since the official start of the coronavirus pandemic and the U.S. death toll is approaching 118,000, with new cases still climbing in 20 states, even as governors push to reopen more businesses.
MarketWatch · 06/18 19:07
CryoLife to offer $100 million of 5-year convertible notes
MarketWatch · 06/18 12:14
CryoLife Announces Offering of Convertible Senior Notes Due 2025
PR Newswire · 06/18 12:05
CryoLife launches convertible debt offering
Seeking Alpha - Article · 06/18 11:25
Cryolife Inc (CRY): Hedge Funds Turning Bearish
In this article we will take a look at whether hedge funds think Cryolife Inc (NYSE:CRY) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy
Insider Monkey · 06/15 00:33
Needham weighs top picks as med techs recover
Seeking Alpha - Article · 05/28 22:57